Barinthus Biotherapeutics plc (BRNS) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts BRNS Hot Sheet
Join SI Premium – FREE
Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q3 EPS of ($0.36), $0.04 better than the analyst estimate of ($0.40).
For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
- Kaiser Aluminum names Fred Stephan as CEO, effective November 2026
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
